Low-Dose Methotrexate to Prevent Recurrent MI and Stroke?

Paul Ridker discusses the Cardiovascular Inflammation Reduction Trial, which will formally test the inflammatory hypothesis.

To continue reading, please log in to the right or request an invitation.